Sustainability
As a pharmaceutical and healthcare company, STADA is responsible for ensuring the group-wide safety of its products and thus also the safety of patients. That’s what SDG 17 is all about.
Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Austria (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
The Phillippines (1)
United Kingdom (3)
Vietnam (2)
Explore STADA
Your opportunity for success with STADA
We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.
Spotlight on STADA's Legal Department.
By Dr. Christoph Dengler,
Tuesday 11 of November was an important day for our factory at Třinec.
By Martin Hefner,
🌟 Grateful for the Growth Opportunities at STADA 🌟
By Wim Denolf, National Sales Manager, EG
The Bad Vilbel production site has achieved another important goal on its path to transformation:
By Dr. Dirk Holtkamp, Sen. Director Operations Germany at Stada Goup
🌟 Reflecting on my experience at Module 2 leadership development training with STADA KeepGrowing 🌟
By Anastassiya Mamedova, Director Regulatory Affairs, Medical Affairs, Commercial Quality and PV …
Over 500 Culture Explorers at STADA!🌍
By Simone Berger,
Looking forward to discussing with representatives of the European Commission,
By Aidan Fry, Director of External Communications, Generics & Specialty/Biosimilars at STADA Group
STADA Voices
Latest news
10/10/2024
EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar
26/07/2024
European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine
24/06/2024
STADA Health Report 2024: Satisfaction with healthcare systems continues to decline
28/05/2024
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, EU and UK
21/05/2024
STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey
10/05/2024
Xbrane, STADA partner with Valorum Biologics to commercialize ranibizumab biosimilar candidate in the US
10/01/2024
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
I’m truly thankful to be part of a company like STADA. Living the purpose ‘Caring for peoples health as a trusted partner’ and promoting a culture of growth creates opportunities for its people to learn and evolve. Working alongside with international leaders, I feel a deep sense of trust and respect that allows everyone in our team to experiment, make mistakes, and learn from them. This unique environment, where simulation and practice are valued as essential parts of progress, empowers us to become better every day.
Thank you, STADA, for the chance to keep growing, together! 🌱
#GrowthMindset #KeepGrowing #STADA
Mélanie Ecks 🙏🏻 Einar Löw 🙏🏻